Skip to main content
Clinical Trials/NCT01527942
NCT01527942
Terminated
Not Applicable

Effect of Intravenous Acetaminophen on Postoperative Pain of Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Placebo-Controlled Trial

Trinity Health Of New England1 site in 1 country34 target enrollmentMarch 2012

Overview

Phase
Not Applicable
Intervention
Acetaminophen
Conditions
Obesity
Sponsor
Trinity Health Of New England
Enrollment
34
Locations
1
Primary Endpoint
Change in Pain Relief Score on the 5-point Pain Relief Score Between Baseline and 24 Hours
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
July 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Trinity Health Of New England
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Morbidly Obese and body mass index (BMI) of 35
  • Between ages 20-17
  • Candidates for Laparoscopic Bariatric Surgery

Exclusion Criteria

  • know hypersensitivity to acetaminophen or opioids
  • impairment in liver function
  • renal dysfunction
  • mental retardation

Arms & Interventions

Arm 1 - Active Drug

Preoperative administration of 1,000 mg IV Acetaminophen will be administered after induction of general anesthesia and prior to incision and every 6 hours thereafter for 24 hours.

Intervention: Acetaminophen

Arm 2 - Placebo

Preoperative IV Placebo (0.9 Sodium Chloride 100 ml) will be administered after induction of general anesthesia and prior to incision and every 6 hours thereafter for 24 hours.

Intervention: Placebo

Outcomes

Primary Outcomes

Change in Pain Relief Score on the 5-point Pain Relief Score Between Baseline and 24 Hours

Time Frame: baseline and 24 hours

The 5-point Pain Relief Score is self-reported and scores range from 0=none, 1=little, 2=some, 3=a lot, 4=complete. Change = (24 hour score - baseline)

Secondary Outcomes

  • Change in Pain Intensity on the 10-point Pain Intensity Scale Between Baseline and 24 Hours(baseline and 24 hours)
  • Response Rate - of 3=Excellent at Hour 24 Using 4-point Global Satisfaction With Regards to Overall Pain Management Rating Scale 0=Poor to 3= Excellent.(24 hours after baseline)

Study Sites (1)

Loading locations...

Similar Trials